UNH vs DGX
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Quest Diagnostics Incorporated, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | DGX |
|---|---|---|
| Price | $427.89 | $209.88 |
| Market cap | $388.59B | $23.23B |
| P/E ratio | 32.3 | 23.2 |
| ROE | 12.18% | 14.54% |
| Profit margin | 2.68% | 9.08% |
| Revenue growth | 2.00% | 9.20% |
| Dividend yield | 2.17% | 1.64% |
| Beta | 0.65 | 0.59 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs DGX in plain English
- UNH is the bigger company — about 16.7× the market cap of DGX.
- DGX is cheaper on earnings (P/E 23.2 vs 32.3).
- DGX earns a higher return on equity (15% vs 12%).
- DGX is growing revenue faster (9% vs 2%).
- UNH has the higher dividend yield (2.17% vs 1.64%).
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
DGX return calculator
See what $1,000 in Quest Diagnostics Incorporated would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.